Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
M. Corradi (Parma, Italy). Breath biomarkers for lung cancer detection: ready for use by the pulmonologist?. Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Is CT-based screening for lung cancer finally ready for prime time? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Breath collection related factors may influence electronic nose ability to detect lung cancer Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Rapid access lung cancer clinics: do you have one? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 The electronic nose: emerging biomarkers in lung cancer diagnostics Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 Year: 2019 Electronic nose as a screening tool for early stage lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Shall we disclose the diagnosis of lung cancer to the patient? Source: Eur Respir J 2006; 28: Suppl. 50, 40s Year: 2006 Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Management of incidental nodules in lung cancer screening: ready for prime-time? Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019 Year: 2019 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Early detection of lung cancer in patients with COPD by eNose technology Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Biomarkers in early-detection of lung cancer: current concepts Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts Year: 2021 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014